FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 263

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
MAZE Nasdaq Maze Therapeutics, Inc. 2830
MBIO Nasdaq Mustang Bio, Inc. 2830
MDCX Nasdaq Medicus Pharma Ltd. 2830
MDWD Nasdaq MediWound Ltd. 2830
MESO Nasdaq Mesoblast Limited 2830
MGNX Nasdaq MacroGenics, Inc. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MITUY Over the counter Mitsui Chemicals, Inc. 2830
MNKD Nasdaq MannKind Corporation 2830
MOLN Nasdaq Molecular Partners AG 2830
MREO Nasdaq Mereo BioPharma Group plc 2830
MRK New York Merck & Co., Inc. 2830
MSLE Nasdaq Satellos Bioscience Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
NATR Nasdaq Natures Sunshine Products, Inc. 2830
NCEL Nasdaq NewcelX Ltd. 2830
NCNA Nasdaq NuCana plc 2830
NEOG Nasdaq Neogen Corporation 2830
NERV Nasdaq Minerva Neurosciences, Inc. 2830
NGEN Nasdaq NervGen Pharma Corp. 2830
NMRA Nasdaq Neumora Therapeutics, Inc. 2830
NNVC NYSE American NanoViricides, Inc. 2830
NRIX Nasdaq Nurix Therapeutics, Inc. 2830
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2830
NTRB Nasdaq Nutriband Inc. 2830
NVCT Nasdaq Nuvectis Pharma, Inc. 2830
OCS Nasdaq Oculis Holding AG 2830
ODTX Nasdaq Odyssey Therapeutics, Inc. 2830
OMER Nasdaq Omeros Corporation 2830
OPK Nasdaq OPKO Health, Inc. 2830
OPTH Nasdaq Optimi Health Corp. 2830
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2830
PASG Nasdaq Passage Bio, Inc. 2830
PBLS Nasdaq Parabilis Medicines, Inc. 2830
PBM Nasdaq Psyence Biomedical Ltd. 2830
PHAR Nasdaq Pharming Group N.V. 2830
PHIO Nasdaq Phio Pharmaceuticals Corp. 2830
PHVS Nasdaq Pharvaris N.V. 2830
PLRZ Nasdaq Polyrizon Ltd. 2830
PLYX Nasdaq Polaryx Therapeutics, Inc. 2830
PPBT Nasdaq Purple Biotech Ltd 2830
PRFX Nasdaq PRF Technologies Ltd. 2830
PRGO New York Perrigo Company plc 2830
PRQR Nasdaq ProQR Therapeutics N.V. 2830
PTGX Nasdaq Protagonist Therapeutics, Inc. 2830
PYPD Nasdaq PolyPid Ltd. 2830
QCLS Nasdaq Q/C Technologies, Inc. 2830
QNTM Nasdaq Quantum BioPharma Ltd. 2830
QTRX Nasdaq Quanterix Corporation 2830
RANI Nasdaq Rani Therapeutics Holdings, Inc. 2830
Results 150 through 200 of 263